2.57 -0.13 (-4.76%)
SCLN
Stock Details
Last Trade:2.57 Change:-0.13 (-4.76%) Prev Close:2.70 Open: 2.73 Days Range:2.56 – 2.73 52 Week Range: 0.85 - 5.33 Volume:366741 P/E: 19.77EPS:0.13
View AllRecent Alerts 02/09/10
Recent Alert on 02/08/10 at 7:09am
SciClone Pharma (SCLN) and Partner Announce Topline Results for ZADAXIN
SciClone Pharma (SCLN) and Partner Announce Topline Results for ZADAXIN
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) and its partner Sigma-Tau S.p.A., announced additional topline results in a clinical study evaluating the potential of ZADAXIN (thymalfasin) to enhance immune response to the MF59 adjuvanted H1N1... Read More
Recent Alert on 02/08/10 at 7:09am
SciClone Pharma (SCLN) and Partner Announce Topline Results for ZADAXIN
SciClone Pharma (SCLN) and Partner Announce Topline Results for ZADAXIN
Recent Alert on 01/12/10 at 6:52am
SciClone Pharma (SCLN) and Sigma-Tau Announce Positive Results of ZADAXIN H1N1 Vaccine Enhancer
SciClone Pharma (SCLN) and Sigma-Tau Announce Positive Results of ZADAXIN H1N1 Vaccine Enhancer
Recent Alert on 01/12/10 at 6:52am
SciClone Pharma (SCLN) and Sigma-Tau Announce Positive Results of ZADAXIN H1N1 Vaccine Enhancer
SciClone Pharma (SCLN) and Sigma-Tau Announce Positive Results of ZADAXIN H1N1 Vaccine Enhancer
View AllRecent Press Releases
Press Release on 02/08/10 at 6:00am
SciClone and Sigma-Tau Announce Additional Positive Results in Clinical Study Examining ZADAXIN's Ability to Enhance Response to H1N1 Vaccine
SciClone and Sigma-Tau Announce Additional Positive Results in Clinical Study Examining ZADAXIN's Ability to Enhance Response to H1N1 Vaccine
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 09/20/09 at 4:50pm
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers